Category: Symptoms
South Korea: XE and XM recombinants may be ‘domestic occurrence’
South Korea’s health authority has detected the XE and XM SARS_CoV-2 recombinant mutations for the first time.
Preprint: 40 mutations in a 16-month case of SARS-CoV-2 infection
Here we describe an approximately 16-month case of SARS-CoV-2 infection in an immunocompromised individual. More...
2004 Research: SARS-CoV-1 associated with viral hepatitis
2004: Liver impairment is commonly reported in up to 60% of patients who suffer from severe acute respiratory syndrome (SARS 1). More...
Up to one hundred times more super-spreaders with Omicron
“A much larger proportion of individuals infected with the new variants are high, very high or super-emitters of airborne viruses: for the original wild type, one in 1,000 infected was a super-emitter; for Delta one in 30; and for Omicron one in 20 or one in 10, depending on the viral load estimate used. More...
Canada: Ontario Risk Assessment for BA.2 to April 5, 2022
“Close monitoring of epidemiological trends since March 21, 2022 (date of mask mandate removal) suggests a corresponding temporal association with a subsequent increase in confirmed COVID-19 cases, percent positivity, and hospitalizations.” More...
UK ONS: 2.7% of the British population reporting Long Covid symptoms
An estimated 1.7 million people living in private households in the UK (2.7% of the population) were experiencing self-reported long COVID as of 5 March 2022
The estimates presented in this analysis relate to self-reported long COVID, as experienced by study participants who responded to a representative survey, rather than clinically diagnosed ongoing symptomatic COVID-19 or post-COVID-19 syndrome in the full population. More...
France: XD Deltacron recombinant update
France has issued its latest epidemiological update which gives more details on the growth and characteristics of the XD Deltacron recombinant. More...
UK: XE growth rate now 12.6% higher than BA.2
“Earlier published growth rates for XE were not significantly different from BA.2, but using the most recent data up to 30 March 2022, XE has a growth rate 12.6% above that of BA.2. More...
Preprint: 100% symptomatic infection with XD recombinant
“This recombinant (XD) exhibits immune escape properties similar to Omicron, while its behavior in mice expressing the human ACE2 receptor is more similar to Delta.” More...
Thailand: first cases of XE and XJ recombinants reported
Thailand has reported its first cases of Omicron XE and XJ. More...